Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Chronic Myeloid Leukemia (CML)

Interventions

DRUG

Imatinib/Acetaminophen

Trial Locations (1)

Novartis Investigative Site, Seoul